Your browser doesn't support javascript.
loading
Understanding Demand for PrEP and Early Experiences of PrEP Use Among Young Adults in Rural Kenya and Uganda: A Qualitative Study.
Camlin, Carol S; Koss, Catherine A; Getahun, Monica; Owino, Lawrence; Itiakorit, Harriet; Akatukwasa, Cecilia; Maeri, Irene; Bakanoma, Robert; Onyango, Anjeline; Atwine, Frederick; Ayieko, James; Kabami, Jane; Mwangwa, Florence; Atukunda, Mucunguzi; Owaraganise, Asiphas; Kwarisiima, Dalsone; Sang, Norton; Bukusi, Elizabeth A; Kamya, Moses R; Petersen, Maya L; Cohen, Craig R; Charlebois, Edwin D; Havlir, Diane V.
Afiliação
  • Camlin CS; Department of Obstetrics, Gynecology & Reproductive Sciences, ANSIRH Program, University of California San Francisco, 1330 Broadway, Suite 1100, Oakland, CA, 94612, USA. carol.camlin@ucsf.edu.
  • Koss CA; Department of Medicine, Center for AIDS Prevention Studies, University of California San Francisco, San Francisco, USA. carol.camlin@ucsf.edu.
  • Getahun M; Department of Medicine, Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco, USA.
  • Owino L; Department of Obstetrics, Gynecology & Reproductive Sciences, ANSIRH Program, University of California San Francisco, 1330 Broadway, Suite 1100, Oakland, CA, 94612, USA.
  • Itiakorit H; Kenya Medical Research Institute, Nairobi, Kenya.
  • Akatukwasa C; Infectious Diseases Research Collaboration, Kampala, Uganda.
  • Maeri I; Infectious Diseases Research Collaboration, Kampala, Uganda.
  • Bakanoma R; Kenya Medical Research Institute, Nairobi, Kenya.
  • Onyango A; Infectious Diseases Research Collaboration, Kampala, Uganda.
  • Atwine F; Kenya Medical Research Institute, Nairobi, Kenya.
  • Ayieko J; Infectious Diseases Research Collaboration, Kampala, Uganda.
  • Kabami J; Kenya Medical Research Institute, Nairobi, Kenya.
  • Mwangwa F; Infectious Diseases Research Collaboration, Kampala, Uganda.
  • Atukunda M; Infectious Diseases Research Collaboration, Kampala, Uganda.
  • Owaraganise A; Infectious Diseases Research Collaboration, Kampala, Uganda.
  • Kwarisiima D; Infectious Diseases Research Collaboration, Kampala, Uganda.
  • Sang N; Infectious Diseases Research Collaboration, Kampala, Uganda.
  • Bukusi EA; Kenya Medical Research Institute, Nairobi, Kenya.
  • Kamya MR; Kenya Medical Research Institute, Nairobi, Kenya.
  • Petersen ML; Infectious Diseases Research Collaboration, Kampala, Uganda.
  • Cohen CR; School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
  • Charlebois ED; Graduate Group in Biostatistics, School of Public Health, University of California Berkeley, Berkeley, USA.
  • Havlir DV; Department of Obstetrics, Gynecology & Reproductive Sciences, ANSIRH Program, University of California San Francisco, 1330 Broadway, Suite 1100, Oakland, CA, 94612, USA.
AIDS Behav ; 24(7): 2149-2162, 2020 Jul.
Article em En | MEDLINE | ID: mdl-31955361
Few studies have sought to understand factors influencing uptake and continuation of pre-exposure prophylaxis (PrEP) among young adults in sub-Saharan Africa in the context of population-based delivery of open-label PrEP. To address this gap, this qualitative study was implemented within the SEARCH study (NCT#01864603) in Kenya and Uganda, which achieved near-universal HIV testing, and offered PrEP in 16 intervention communities beginning in 2016-2017. Focus group discussions (8 groups, n = 88 participants) and in-depth interviews (n = 23) with young adults who initiated or declined PrEP were conducted in five communities, to explore PrEP-related beliefs and attitudes, HIV risk perceptions, motivations for uptake and continuation, and experiences. Grounded theoretical methods were used to analyze data. Young people felt personally vulnerable to HIV, but perceived the severity of HIV to be low, due to the success of antiretroviral therapy (ART): daily pill-taking was more threatening than the disease itself. Motivations for PrEP were highly gendered: young men viewed PrEP as a vehicle for safely pursuing multiple partners, while young women saw PrEP as a means to control risks in the context of engagement in transactional sex and limited agency to negotiate condom use and partner testing. Rumors, HIV/ART-related stigma, and desire for "proof" of efficacy militated against uptake, and many women required partners' permission to take PrEP. Uptake was motivated by high perceived HIV risk, and beliefs that PrEP use supported life goals. PrEP was often discontinued due to dissolution of partnerships/changing risk, unsupportive partners/peers, or early side effects/pill burden. Despite high perceived risks and interest, PrEP was received with moral ambivalence because of its associations with HIV/ART and stigmatized behaviors. Delivery models that promote youth access, frame messaging on wellness and goals, and foster partner and peer support, may facilitate uptake among young people.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / Fármacos Anti-HIV / Profilaxia Pré-Exposição Tipo de estudo: Prognostic_studies / Qualitative_research Limite: Adolescent / Adult / Female / Humans / Male País/Região como assunto: Africa Idioma: En Revista: AIDS Behav Assunto da revista: CIENCIAS DO COMPORTAMENTO / SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / Fármacos Anti-HIV / Profilaxia Pré-Exposição Tipo de estudo: Prognostic_studies / Qualitative_research Limite: Adolescent / Adult / Female / Humans / Male País/Região como assunto: Africa Idioma: En Revista: AIDS Behav Assunto da revista: CIENCIAS DO COMPORTAMENTO / SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos